ZIVO Bioscience (NASDAQ:ZIVO) Stock Price Crosses Above 50-Day Moving Average - Should You Sell?

Key Points

• ZIVO Bioscience shares have recently exceeded their fifty-day moving average, hitting a high of $19.65 before settling at $18.04 during trading.
• The company's market capitalization stands at $68.86 million, with a price-to-earnings ratio of -3.70.
• ZIVO operates in the biotech and agtech sectors, focusing on natural bioactive ingredients derived from proprietary algae cultures.

Shares of ZIVO Bioscience, Inc. (NASDAQ:ZIVO - ) passed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $13.86 and traded as high as $19.65. ZIVO Bioscience shares last traded at $18.04, with a volume of 1,719 shares trading hands.

ZIVO Bioscience Trading Down 2.4%

The firm's 50 day simple moving average is $13.86 and its 200-day simple moving average is $16.35. The stock has a market capitalization of $68.86 million, a price-to-earnings ratio of -3.70 and a beta of -0.06.

About ZIVO Bioscience

ZIVO Bioscience, Inc, a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.